RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -82.1% | 23,784 | -64.0% | 0.00% | – |
| Q2 2022 | $56,000 | -73.1% | 66,129 | +75.1% | 0.00% | – |
| Q1 2022 | $208,000 | -22.4% | 37,765 | +151.8% | 0.00% | – |
| Q3 2021 | $268,000 | -78.2% | 15,000 | -70.2% | 0.00% | – |
| Q2 2021 | $1,228,000 | -65.7% | 50,300 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $3,578,000 | +4210.8% | 135,028 | +1130.1% | 0.00% | – |
| Q4 2020 | $83,000 | -46.1% | 10,977 | -64.2% | 0.00% | – |
| Q3 2020 | $154,000 | – | 30,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
| Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
| HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
| Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
| EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
| Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
| Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
| Leap Investments LP | 14,100 | $222,000 | 0.30% |
| ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
| Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |